in each of the population groups, a significant difference was found between ac-1202 and placebo in mean change from baseline in adas-cog score on day 45: 1.9 point difference, p = 0.0235 in itt; 2.53 point difference, p = 0.0324 in per protocol; 2.6 point difference, p = 0.0215 in dosage compliant.